Search filters

List of works by Christine Rauschkolb

A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy

scientific article

A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain

scientific article

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

scientific article

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations

scientific article

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

scientific article published on 09 April 2012

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

scientific article

Dose conversion between tapentadol immediate and extended release for low back pain.

scientific article published on January 2010

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled pha

scientific article published in January 2010

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

scientific article published in August 2010

Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations

scientific article published on December 2009

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

scientific article published on 11 December 2007

Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial

scientific article published on 28 September 2015

Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain

scientific article

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations

scientific article published on July 2015

Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations

scientific article published on 5 July 2012

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

scientific article published on 06 March 2010

Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations

scientific article published on 16 December 2015

Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations

scientific article published on 24 May 2014

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

scientific article published on January 1, 2011

Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials

scientific article published on June 2014

Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain

scientific article published on May 1, 2013